Quantcast

UAS LifeSciences’ Kids Cubes Probiotic Win NutrAward Best Finished Product

March 27, 2014

Kids Cubes, a new chewable probiotic, from UAS LifeSciences, won the NutrAward competition by NEXT Innovation Summit.

Wausau, WI (PRWEB) March 27, 2014

Kids Cubes, a new chewable probiotic, from UAS LifeSciences, won the NutrAward competition by NEXT Innovation Summit (formerly Nutracon) that rewards companies for:

·         Viable Product

·         Emerging Category

·         Creative Product Concept

·         Distinct Health Application

·         Unique Packaging

·         Matchless Marketing

UAS was voted the award by the 65,000 practitioners, retailers and other industry professionals attending Natural Products Expo West days before the show. Kevin Mehring, President of UAS LifeSciences, commented, “We are grateful that the natural products industry has recognized our company and all of the changes we have made with our new team, new quality process, new manufacturing capabilities and new product branding program. We have dedicated ourselves to health food retailers and have worked hard to produce probiotics that will be a foundation for building their business.”

Kids Cubes Probiotics incorporate the extensively studied probiotic strain, Lactobacillus acidophilus DDS®-1 with 800 IU of Vitamin D3 in a tasty vanilla chewable product that has appeal to kids and adults too. The product is room temperature stable, sugar-free, non-GMO and gluten-free.

Equally important, the certified sustainable palm oil in the formula ensures environmental support to minimize deforestation and support fair labor practices. The striking packaging includes three blister packs of 20 cubes each for a 60-day supply.

In addition, UAS LifeSciences has teamed up with Vitamin Angels to donate 25¢ for every package of Kids Cubes sold. Vitamin Angels helps at-risk populations around the world by providing important nutrients that are a foundation for good health.

Extensively Studied Probiotic Strain for Optimum Efficacy

UAS LifeSciences selected L. acidophilus DDS-1 as the probiotic foundation for its product because the strain has been the subject of a variety of in vitro, animal and human studies. According to Chief Scientific Officer, Dr. Greg Leyer, “Kids Cubes was our first new product introduction and we selected the premier probiotic strain as its foundation. Kids Cubes is an example of the many new probiotic formulations we have introduced and have in our pipeline. Our plan is to participate in and work with leading researchers around the world to develop probiotic formulations based upon good scientific investigation.”

Dedicated to Superior Probiotics

UAS LifeSciences has made it their mission to manufacture and market superior probiotics, building upon years of experience in the field. According to Vice President of Sales and Marketing, Ken Seguine, “Excellence in probiotics requires a depth of knowledge that is rare in this industry. UP4 Probiotics build upon a legacy of probiotic quality adding scientific leadership to our products for our natural product retailer partners.”

About UAS LifeSciences

Founded in 1979, UAS LifeSciences, has delivered the highest quality, science-backed probiotics to the natural products marketplace for more than thirty years. Strictly dedicated to probiotic based supplements, UAS is committed to designing innovative and effective formulations based on L. acidophilus DDS®-1, a strain that has been researched and tested rigorously for decades. UAS LifeSciences’ products are sold to natural products retailers, health professionals and private label customers in the U.S. and Canada. The company is fully integrated from formulation through manufacturing, packaging and marketing, and adheres to the highest quality standards. UAS has recently made significant investments in research, streamlining operations through new technology and innovations, and ultimately introducing state-of-the-art products.

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/03/prweb11708253.htm


Source: prweb



comments powered by Disqus